Form 4: Amgen SVP Rachna Khosla Reports Stock Disposal
SEC Form 4 Filing
Amgen's SVP of Business Development, Rachna Khosla, reports the disposal of common stock to cover tax obligations.
Summary
- On April 30, 2025, Rachna Khosla, SVP of Business Development at Amgen Inc., reported a transaction involving Amgen's common stock.
- Khosla disposed of 74 shares of common stock at a price of $288.56 per share.
- This transaction was categorized under transaction code 'F', indicating it was likely to cover tax obligations related to vesting of restricted stock units (RSUs).
- Following the transaction, Khosla directly owns 9,266 shares of Amgen common stock, which includes 144 Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard practice of covering tax obligations related to equity compensation.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of stock disposal transaction and filing date. |
Keywords
Amgen, Rachna Khosla, Form 4, Stock Disposal, Insider Trading, Dividend Equivalents, RSUs, AMGN, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.